Edwards Lifesciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EW and other ETFs, options, and stocks.

About EW

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. 

CEO
Bernard J. Zovighian
CEOBernard J. Zovighian
Employees
15,800
Employees15,800
Headquarters
Irvine, California
HeadquartersIrvine, California
Founded
1958
Founded1958
Employees
15,800
Employees15,800

EW Key Statistics

Market cap
42.79B
Market cap42.79B
Price-Earnings ratio
49.80
Price-Earnings ratio49.80
Dividend yield
Dividend yield
Average volume
4.15M
Average volume4.15M
High today
$73.16
High today$73.16
Low today
$72.52
Low today$72.52
Open price
$72.59
Open price$72.59
Volume
122.18K
Volume122.18K
52 Week high
$83.00
52 Week high$83.00
52 Week low
$64.89
52 Week low$64.89

EW News

Simply Wall St 6d
How Edwards Lifesciences' Next-Gen Heart Valve Launch in Thailand Could Shape Its Growth Outlook

Edwards Lifesciences recently launched its next-generation transcatheter heart valve in Thailand, featuring calcification-resistant tissue and improved sealing...

How Edwards Lifesciences' Next-Gen Heart Valve Launch in Thailand Could Shape Its Growth Outlook
Seeking Alpha 6d
Edwards Lifesciences slips as Oppenheimer downgrades on upcoming data

Shares of Edwards Lifesciences (NYSE:EW) fell on Wednesday after Oppenheimer downgraded the cardiac device maker to Perform from Outperform, citing concerns ove...

Edwards Lifesciences slips as Oppenheimer downgrades on upcoming data
TipRanks 6d
Oppenheimer downgrades Edwards Lifesciences on long-range plan concerns

As previously reported, Oppenheimer analyst Suraj Kalia downgraded Edwards Lifesciences (EW) to Perform from Outperform with no price target Third-party vendor...

Analyst ratings

53%

of 36 ratings
Buy
52.8%
Hold
44.4%
Sell
2.8%

People also own

Based on the portfolios of people who own EW. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.